Kodiak Sciences Inc (KOD)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 454.82M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 11.60
52W Low
$ 1.92
Dividend Yield
0.00%
Beta
2.42
Technicals
50-Day MA
5.3346
200-Day MA
5.2866
52 Week High
11.5999
52 Week Low
1.92
About KOD
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
Employees
113
Headquarters
Palo Alto, CA
CEO
Dr. Victor Perlroth M.D.